United Guardian Inc's Customers Performance
UG
|
UG's Source of Revenues |
United Guardian Inc's Corporate Customers have recorded an advance in their cost of revenue by 3.38 % in the 4 quarter 2023 year on year, sequentially costs of revenue grew by 1.11 %. During the corresponding time, United Guardian Inc revenue deteriorated by -5.64 % year on year, sequentially revenue fell by -14.73 %. While revenue at the United Guardian Inc 's corporate clients recorded rose by 58.25 % year on year, sequentially revenue grew by 59.56 %.
• List of UG Customers
|
|
United Guardian Inc's Customers have recorded an advance in their cost of revenue by 3.38 % in the 4 quarter 2023 year on year, sequentially costs of revenue grew by 1.11 %, for the same period United Guardian Inc revnue deteriorated by -5.64 % year on year, sequentially revnue fell by -14.73 %.
• List of UG Customers
Select the Relationship:
|
|
Select the Category:
|
|
Customers Net Income grew in Q4 by |
Customers Net margin fell to % |
11.43 % |
9.43 % |
United Guardian Inc's Comment on Sales, Marketing and Customers
The Company’s personal care/cosmetic ingredients are marketed and sold globally
by six marketing partners. Those marketing partners in turn market and distribute
those products to their customers. Although the Company depends on those marketing
partners for the marketing and distribution of its personal care products, it
is confident that if any of its marketing partners were to decide not to sell
the Company’s products, or if the Company chose to replace one or more of
those marketing partners, it would be able to put in place new marketing agreements
to service its customers in any of the geographic areas affected. If necessary,
the Company would also be able to sell directly to the end users of its products
until such time as a new marketing partner is put in place.
The Company’s pharmaceutical products are sold to, and distributed by, full-line
drug wholesalers throughout the United States. It’s medical and specialty
industrial products are sold directly by the Company to the end users of those
products or, in some cases, to contract manufacturers used by some of those end
users.
|
United Guardian Inc's Comment on Sales, Marketing and Customers
The Company’s personal care/cosmetic ingredients are marketed and sold globally
by six marketing partners. Those marketing partners in turn market and distribute
those products to their customers. Although the Company depends on those marketing
partners for the marketing and distribution of its personal care products, it
is confident that if any of its marketing partners were to decide not to sell
the Company’s products, or if the Company chose to replace one or more of
those marketing partners, it would be able to put in place new marketing agreements
to service its customers in any of the geographic areas affected. If necessary,
the Company would also be able to sell directly to the end users of its products
until such time as a new marketing partner is put in place.
The Company’s pharmaceutical products are sold to, and distributed by, full-line
drug wholesalers throughout the United States. It’s medical and specialty
industrial products are sold directly by the Company to the end users of those
products or, in some cases, to contract manufacturers used by some of those end
users.
UG's vs. Customers, Data
(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)
COMPANY NAME |
MARKET CAP |
REVENUES |
INCOME |
EMPLOYEES |
United guardian Inc |
34.89 |
10.89 |
2.58 |
34 |
Abbvie inc |
325,570.70 |
54,318.00 |
4,873.00 |
50,000 |
Abbott Laboratories |
199,532.57 |
40,109.00 |
5,723.00 |
113,000 |
Aecom |
13,279.60 |
14,894.08 |
111.97 |
92,000 |
Albany International Corp |
2,961.74 |
1,147.72 |
111.61 |
3,900 |
Autoliv Inc |
10,573.75 |
8,112.00 |
363.00 |
54,600 |
Amgen Inc |
152,904.52 |
28,190.00 |
6,717.00 |
24,200 |
Arq Inc |
188.98 |
0.00 |
0.00 |
0 |
Ashland Inc |
5,236.21 |
2,191.00 |
178.00 |
11,000 |
Avient Corporation |
3,811.45 |
3,142.50 |
76.20 |
0 |
Avon Products Inc |
0.00 |
2,696.40 |
-450.80 |
33,200 |
Biogen Inc |
31,413.80 |
9,835.60 |
1,161.50 |
9,610 |
Bristol myers Squibb Company |
112,745.01 |
45,006.00 |
8,040.00 |
32,200 |
Sustainable Projects Group Inc |
0.00 |
0.01 |
-0.49 |
1 |
Cabot Corporation |
5,153.48 |
3,931.00 |
484.00 |
4,300 |
Church and Dwight Co Inc |
25,941.90 |
5,775.30 |
437.20 |
5,100 |
Colgate palmolive Company |
74,770.76 |
19,457.00 |
2,455.00 |
33,800 |
The Clorox Company |
19,080.57 |
7,310.00 |
93.00 |
9,000 |
Coty Inc |
11,036.69 |
6,007.70 |
343.50 |
10,600 |
Crown Crafts Inc |
53.97 |
86.50 |
4.72 |
135 |
Dole Plc |
1,135.08 |
6,454.40 |
16.81 |
3,850 |
Ecolab Inc |
66,151.16 |
15,320.20 |
1,393.00 |
47,000 |
Est e Lauder Companies Inc |
55,494.00 |
15,157.00 |
483.00 |
63,000 |
Corning Inc |
28,161.41 |
12,588.00 |
648.00 |
61,200 |
Green Brick Partners Inc |
2,682.95 |
1,758.42 |
287.48 |
0 |
Helen Of Troy Limited |
2,688.25 |
2,082.07 |
162.55 |
1,610 |
Huntsman Corporation |
4,504.25 |
6,111.00 |
153.00 |
15,000 |
International Flavors and Fragrances Inc |
21,963.81 |
11,479.00 |
-2,563.00 |
24,000 |
Inter Parfums Inc |
4,333.12 |
1,317.08 |
187.78 |
311 |
Jubilant Flame International Ltd |
0.87 |
0.04 |
-0.07 |
3 |
Kimberly clark Corporation |
43,795.28 |
20,431.00 |
1,764.00 |
45,000 |
Kronos Worldwide inc |
1,341.69 |
1,665.90 |
-49.10 |
2,260 |
Quaker Chemical Corporation |
3,661.21 |
1,969.76 |
16.70 |
2,020 |
Nl Industries inc |
330.97 |
161.22 |
0.58 |
2,776 |
Nn Inc |
176.45 |
489.27 |
-50.15 |
4,730 |
Procter and Gamble Co |
401,916.43 |
83,933.00 |
14,865.00 |
106,000 |
Revlon Inc |
4.41 |
2,005.80 |
-485.50 |
6,000 |
Rayonier Advanced Materials Inc |
290.26 |
1,719.11 |
-36.65 |
1,200 |
Smart Sand Inc |
71.28 |
295.97 |
4.65 |
103 |
Sensient Technologies Corp |
2,853.38 |
1,456.45 |
93.39 |
4,083 |
Thermo Fisher Scientific Inc |
225,524.53 |
42,857.00 |
5,955.00 |
130,000 |
Trecora Resources |
231.52 |
301.32 |
8.99 |
310 |
Tronox Holdings Plc |
2,684.44 |
2,850.00 |
-314.00 |
4,300 |
Tupperware Brands Corporation |
61.09 |
1,303.10 |
-232.50 |
13,000 |
Unilever Plc |
0.00 |
66,756.48 |
7,996.80 |
0 |
Usana Health Sciences Inc |
918.74 |
920.32 |
63.79 |
1,788 |
Valhi inc |
487.75 |
1,921.70 |
2.90 |
2,995 |
Westlake Corporation |
19,438.34 |
12,548.00 |
522.00 |
8,870 |
Westlake Chemical Partners Lp |
785.42 |
1,190.79 |
334.63 |
141 |
SUBTOTAL |
1,885,943.77 |
569,253.18 |
61,950.49 |
1,038,196 |
|